DEBORAH OUTLAW

Legislation and regulatory issues impacting the 340B program

Issues impacting the 340B program

Issues impacting massage therapy industry, including pain management and reimbursement

Legislation to protect the 340B program

Issues impacting massage therapy industry, including pain management and reimbursement

Issues impacting massage therapy industry, including pain management and reimbursement

Legislation and regulatory issues impacting the 340B program

Issues impacting the 340B program

Issues impacting massage therapy industry, including pain management and reimbursement

Legislation and regulatory issues impacting the 340B program

Issues impacting the 340B program

Issues of interest on coverage of integrated services including massage therapy, and pain management including massage therapy

issues relating to the 340B drug program

340B drug pricing program; Medicare and Medicaid;

Issues of interest on coverage of integrated services including massage therapy, and pain management including massage therapy

340B drug pricing program; Medicare and Medicaid;

issues relating to the 340B drug program

Issues of interest on coverage of integrated services including massage therapy, and pain management including massage therapy

340B drug pricing program; Medicare and Medicaid;

issues relating to the 340B drug program

Issues of interest on coverage of integrated services including massage therapy, and pain management including massage therapy

issues relating to the 340B drug program

340B drug pricing program; Medicare and Medicaid;

Issues of interest on coverage of integrated services including massage therapy, and pain management including massage therapy

issues relating to the 340B drug program

340B drug pricing program; Medicare and Medicaid;

Issues of interest on coverage of integrated services including massage therapy, and pain management including massage therapy

issues relating to the 340B drug program

340B drug pricing program; Medicare and Medicaid;

Issues of interest on coverage of integrated services including massage therapy

issues relating to the 340B drug program

340B drug pricing program; Medicare and Medicaid;

340B drug pricing program; Medicare and Medicaid;

issues relating to the 340B drug program

Issues of interest on coverage of integrated services including massage therapy

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

congressional efforts to support the 340B drug pricing program

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

congressional efforts to support the 340B drug pricing program

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

congressional efforts to support the 340B drug pricing program

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

congressional efforts to support the 340B drug pricing program

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

congressional efforts to support the 340B drug pricing program

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

congressional efforts to support the 340B drug pricing program

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

congressional efforts to support the 340B drug pricing program

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

congressional efforts to support the 340B drug pricing program

congressional efforts to ensure the appropriate operation of the 340B drug program, for covered entities and their contract pharmacies

legislative activities to enhance access to massage therapy as an alternative to opioid use; appropriations efforts to ensure funding for NIH and the VA.

Legislative interest in addressing chronic and acute pain, as well as opioid abuse and misuse and utilization of non opioid therapies to address pain.

legislative interest in drug pricing reform, and issues impacting the provision of drugs through contract pharmacies.

drug pricing legislation; 340B issues; hospital issues.

Legislative interest in addressing chronic and acute pain, as well as opioid abuse and misuse and utilization of non opioid therapies to address pain.

legislative interest in drug pricing reform, and issues impacting the provision of drugs through contract pharmacies.

drug pricing legislation; 340B issues; hospital issues.

congressional hearings and related legislative interest in drug pricing reform.

drug pricing legislation; 340B issues; hospital issues.

congressional hearings and related legislative interest in drug pricing reform.

drug pricing legislation; 340B issues; hospital issues.

Annual appropriations bills to support access to massage therapy and integrative health services to address pain issues.

Legislation and regulations to ensure access to care for certain complementary and integrative therapies, as recommended by the HHS Pain Task Force, and to enact legislation addressing coverage of same.

congressional hearings and related legislative interest in drug pricing reform.

drug pricing legislation; 340B issues; hospital issues.

Access to care for services to address pain issues; implementation issues surrounding the HHS Pain Task Force.

congressional hearings and related legislative interest in drug pricing reform.

drug pricing legislation; 340B issues; hospital issues.

drug pricing legislation; 340B issues; hospital issues.

congressional hearings and related legislative interest in drug pricing reform.

drug pricing legislation; 340B issues; hospital issues.

congressional hearings and related legislative interest in drug pricing reform.

Legislation impacting the ability of certain safety net providers to access the 340B program.

Federal health care initiatives that could impact access to certain prescription drugs for safety net hospitals and other 340B providers.

Federal health care initiatives that could impact access to certain prescription drugs for safety net hospitals and other 340B providers.

Legislation impacting the ability of certain safety net providers to access the 340B program.

Education to increase awareness of the value of massage therapy as an integrative component of medicine and the need to increase research on massage therapy, particularly for pain management.

Federal health care initiatives that could impact access to certain prescription drugs for safety net hospitals and other 340B providers.

Legislation impacting the ability of certain safety net providers to access the 340B program.

Supporting research on gene and cell therapy

Education to increase awareness of the value of massage therapy as an integrative component of medicine and the need to increase research on massage therapy, particularly for pain management.

Legislation impacting the ability of certain safety net providers to access the 340B program.

Federal health care initiatives that could impact access to certain prescription drugs for safety net hospitals and other 340B providers.

Legislation to repeal and replace the Affordable Care Act; other federal health care initiatives that could impact access to certain prescription drugs for safety net hospitals and other 340B providers.

Legislation impacting the ability of certain safety net providers to access the 340B program.

Efforts to repeal and replace the Affordable Care Act, with specific emphasis on diabetes policies that could impact access to DSMT.

Diabetes Prevention Program funding.

Legislative initiatives to increase access to DSMT; legislative issues relative to funding for the Diabetes Prevention Program, and implementation of the Medicare Diabetes Prevention Program.

Legislation to repeal and replace the Affordable Care Act; other federal health care initiatives that could impact access to certain prescription drugs for safety net providers.

Legislation to repeal and replace the Affordable Care Act; other federal health care initiatives that could impact access to certain prescription drugs for safety net providers.

Efforts to repeal and replace the Affordable Care Act, with specific emphasis on diabetes policies that could impact access to DSMT.

Diabetes Prevention Program funding.

Legislative initiatives to increase access to DSMT; legislative issues relative to funding for the Diabetes Prevention Program, and implementation of the Medicare Diabetes Prevention Program.

Regulatory proposals that may impact massage therapy

Legislation to repeal and replace the Affordable Care Act; other federal health care initiatives that could impact access to certain prescription drugs for safety net providers.

Efforts to repeal and replace the Affordable Care Act, with specific emphasis on diabetes policies that could impact access to DSMT.

Legislative initiatives to increase access to DSMT; legislative issues relative to funding for the Diabetes Prevention Program, and implementation of the Medicare Diabetes Prevention Program.

Diabetes Prevention Program funding.

General regulatory and legislative efforts that support the provision of diabetes self management training and education.

. Other regulatory efforts of interest to the diabetes community impacting the provision of diabetes testing supplies, reimbursement, and quality. Appropriations to support CDC diabetes prevention program.

H.R. 1726; S. 1345, legislation to enhance access to diabetes education. Other legislation impacting the provision of MNT and other bills of interest to the diabetes community.

Issues pertaining to the 340B drug program, including proposed 340B regulatory guidance issued by HRSA.

. Other regulatory efforts of interest to the diabetes community impacting the provision of diabetes testing supplies, reimbursement, and quality. Appropriations to support CDC diabetes prevention program.

H.R. 1726; S. 1345, legislation to enhance access to diabetes education. Other legislation impacting the provision of MNT and other bills of interest to the diabetes community. regulatory actions to implement the Diabetes Prevention Program.

General regulatory and legislative efforts that support the provision of diabetes self management training and education.

Issues pertaining to the 340B drug program, including proposed 340B regulatory guidance issued by HRSA.

. Other regulatory efforts of interest to the diabetes community impacting the provision of diabetes testing supplies, reimbursement, and quality. Appropriations to support CDC diabetes prevention program.

H.R. 1726; S. 1345, legislation to enhance access to diabetes education. Other legislation impacting the provision of MNT and other bills of interest to the diabetes community.

General regulatory and legislative efforts that support the provision of diabetes self management training and education.

S. 1345/H.R. 1726: legislation to include certain qualified diabetes educators as providers of DSMT; other legislation to enhance access to care for individuals with diabetes.

H.R. 1726; S. 1345, legislation to enhance access to diabetes education. Other legislation impacting the provision of MNT and other bills of interest to the diabetes community.

General regulatory and legislative efforts that support the provision of diabetes self management training and education.

. Other regulatory efforts of interest to the diabetes community impacting the provision of diabetes testing supplies, reimbursement, and quality. Appropriations to support CDC diabetes prevention program.

Issues pertaining to the 340B drug program, including proposed 340B regulatory guidance issued by HRSA.

S. 1345/H.R. 1726: legislation to include certain qualified diabetes educators as providers of DSMT; other legislation to enhance access to care for individuals with diabetes.

H.R. 1726 and S. 1345, legislation to promote access to quality DSMT for Medicare patients; legislation to promote adoption of Health IT to foster access to DSMT; legislation of interest to individuals with diabetes and providers of care, concerning diabetes prevention and treatment, coverage of continuous glucose monitors, and related issues. Regulatory issues impacting access to insulin pumps for individuals with diabetes under competitive bidding.

H.R. 1726 and S. 1345, legislation to promote access to quality DSMT for Medicare patients; legislation to promote adoption of Health IT to foster access to DSMT; legislation of interest to individuals with diabetes and providers of care, concerning diabetes prevention and treatment, coverage of continuous glucose monitors, and related issues. Regulatory issues impacting access to insulin pumps for individuals with diabetes under competitive bidding.

H.R. 1726, legislation to promote access to quality DSMT for Medicare patients; legislation to promote adoption of Health IT to foster access to DSMT; legislation of interest to individuals with diabetes and providers of care, concerning diabetes prevention and treatment, coverage of continuous glucose monitors, and related issues. Regulatory issues impacting access to insulin pumps for individuals with diabetes under competitive bidding.

H.R. 1274/S. 945: legislation to improve access to quality DSMT. Legislation and regulatory initiatives of interest to diabetes educators and patients with diabetes to improve diabetes screening, reimbursement for care, care coordination and quality.

S. 1274/S. 945 Legislation to ensure access to diabetes self management training (DSMT) by qualified diabetes educators. Other legislation impacting diabetes quality care. CMS regulations impacting access to DSMT.

H.R. 1274 and S. 945, legislation to increase access to diabetes self management training in the Medicare program; legislation that may impact access and treatment to health services by qualified diabetes educators for patients with diabetes; legislation to promote telehealth services for Medicare patients

S. 945 and H.R. 1274, legislation to increase access to diabetes education by specially trained health professionals. Other legislation, including implementation of the Affordable Care Act, that would impact access to diabetes treatment and health outcomes for people with diabetes.

Legislation to increase access to tinnitus treatment and prevention through expanded research, to benefit veteran populations with tinnitus.

S. 945 and H.R. 1274, legislation to enhance access to quality diabetes education services. Legislative issues pertaining to Medicare coverage, coding and reimbursement, and implementation of the Affordable Care Act as it pertains to diabetes and the profession of diabetes education.

H.R. 1274 and S. 945, legislation to ensure access to quality diabetes self management training; other legislation of interest to the diabetes community that impacts access to care and equitable reimbursement for providers of DSMT, including CBO scoring of prevention services, treatment of obesity and DSMT, gestational diabetes and enhancement of health IT.

H.R. 1443, legislation to promote research into the prevention, treatment and cure of tinnitus by the Department of Veterans Affairs.

Legislation to promote enhanced research into tinnitus by the National Institutes of Health and ohter general legislation of interest to tinnitus researchers and patients.

Congressional interest and efforts impacting the 340B prescription drug program.

H.R. 1443, legislation to enhance access to treatment for veterans with tinnitus, in order to ensure better prevention, treatment and development of a cure for this disorder.

Legislation to ensure adequate funding of medical research on tinnitus.

H.R. 1274 and S. 945, legislation to enhance access to diabetes education services for Medicare beneficiaries by certain health care providers. Legislation and regulatory actions impacting the provision of diabetes education under implementation of the Affordable Care Act. Legislation to enhance prevention, treatment and access to care for individuals with diabetes.

H.R. 1443, legislation to enhance research on tinnitus by the Department of Veterans Affairs.

Legislation to promote research by NIDCD/NIH to prevent, treat and cure tinnitus.

H.R. 1274, legislation to enhance access to diabetes education for certain providers. Legislation to support diabetes prevention, treatment and access to care for patients with diabetes or those at high risk.

Legislation to promote research, diagnosis and improved treatment of tinnitus, including the Congressionally Directed Medical Research Program, as well as the National Institutes of Health.

Legislation to promote research of tinnitus at the Department of Veterans Affairs.

Legislation to ensure access to DSMT by certain credentialled diabetes providers: H.R. 2787 and S. 1468. Other legislation impacting the provision of diabetes care and ensuring access to care for individuals with diabetes. Regulatory initiatives resulting from passage of the Affordable Care Act that impacts the provision and availability of diabetes care.